Calculus Capital
Edit

Calculus Capital

https://www.calculuscapital.com
Last activity: 09.09.2026
Active
Calculus Capital is a specialist in creating and managing private equity funds for individuals. Calculus Capital is a pioneer in the tax-efficient industry having set up the UK’s first approved EIS fund in 1999. Since then we have launched 21 EIS funds and 5 VCT share class issues.

The firms focus and investment has remained consistent: building diversified portfolios across a multitude of sectors, of smaller, UK, entrepreneurial growth companies and creating value for our investors through our multi award winning funds. We have provided significant results for our clients either via tax free dividends (for our VCT investors) or tax free capital gains (for our EIS investors).

In addition, we have launched a new fund in June 2019, the UK Creative Content EIS Fund in association with the British Film Institute.

Calculus Capital is authorised and regulated by the Financial Conduct Authority.
News
332
Portfolio
7
Mentions
41
Location: United Kingdom, England, London
Employees: 11-50
Founded date: 1999

Portfolio 7

DateNameWebsiteTotal RaisedLocation
09.09.2026CloudNCcloudnc.com$77.07MUnited Kin...
14.05.2026Resurrect ...resurrect.bio$20.4MUnited Kin...
06.10.2025Trogenixtrogenix.com$94.43MUnited Kin...
28.08.2025EnsiliTechensilitech.com$7.18MUnited Kin...
08.09.2022Optalitixoptalitix.com$7.62M-
07.02.2018Open Energ...openenergymarket.com$4.16MUnited Kin...
09.01.2017Jumptasticjumptastic.uk$3.73MUnited Kin...

News 332

DateTitleDescription
18.03.2026Resurrect Bio and Corteva Join Forces to Unlock Nature’s Own Defenses in Corn-
23.02.2026Wonderhood mastermind new Waitrose and Hargreaves Lansdown adverts-
18.02.2026Calculus invests in Resurrect Bio-
27.01.2026Beyond the Usual Suspects: Rethinking Business Relief for IHT Planning-
19.01.2026Oxford BioTherapeutics and C4X recognised in the 2026 edition of The Sunday Times 100 Tech-
16.12.2025Smartr365 Mortgage Technology Expansion-
10.12.2025Wonderhood Studios produce Waitrose Christmas advert-
10.12.2025Oxford BioTherapeutics Signs Strategic Collaboration with GSK to Discover Novel Antibody-Based Cancer Therapeutics-
26.11.2025Autumn Budget 2025 Response-
05.11.2025Calculus successfully exits employee engagement platform Mo (Thanksbox Limited)-
Show more

Mentions in press and media 41

DateTitleDescription
09.09.2026Startup Funding News Today, September 9, 2026: Cognition AI, Algomatic Dynamics, QNu Labs, VideoGen & MoreToday’s funding activity offers a revealing snapshot of where VC firms are placing their biggest bets. Investors will still write enormous checks for AI companies showing extraordinary commercial velocity, but below the megadeals, money is ...
09.09.2026CloudNC lands $20M to expand its AI software for precision manufacturingLondon precision machining software company CloudNC has raised $20 million in new investment capital. Nimble Ventures leads the round, with participation from other investors including Calculus Venture Capital, Entrepreneur First, and LM Ve...
19.05.2026Resurrect Bio Secures $10.3M to Revolutionize Crop Disease Resistance with AI Gene-EditingResurrect Bio announced a successful $10.3 million Series A funding close. This oversubscribed round powers its cutting-edge gene-editing technology. The UK-based biotech company targets pervasive crop diseases. It reactivates plants' inher...
14.05.2026Resurrect Bio: $10.3 Million Oversubscribed Series A Raised To Accelerate Crop Disease ResistanceResurrect Bio, a biotechnology company developing disease-resistant crops through gene editing, announced the final close of its Series A funding round at $10.3 million, oversubscribed from the company’s previously announced $8.1 million in...
13.05.2026Resurrect Bio expands Series A to $10.3m to scale tech helping plants to defend themselves[Disclosure: AgFunderNews’ parent company AgFunder is an investor in Resurrect Bio] UK-based Resurrect Bio—a startup equipping crops with genetic defenses against disease—has announced the final close of its Series A round at $10.3 million....
19.02.2026Resurrect Bio raises $8.1m to unlock plants’ innate disease resistance capabilities[Disclosure: AgFunderNews’ parent company AgFunder is an investor in Resurrect Bio] – UK-based Resurrect Bio—a startup equipping crops with genetic defenses against disease—has announced the initial closing of its Series A round at $8.1 mil...
06.11.2025DIGIT Deal Roundup | October 2025Welcome to October 2025’s DIGIT Deal Roundup. Christmas came very early for a raft of Scottish firms last month, with tens of millions in fresh investment targeting Scotland’s medtech stars, robot builders, EV makers, and agri-tech innovato...
13.10.2025Trogenix: $95 Million Series A Closed For Advancing Clinical Development Of Curative Cancer TherapiesTrogenix, a biotech company dedicated to developing innovative therapies for cancer treatment, announced the closing of its Series A financing round at £70 million (approximately $95 million). This funding will accelerate the development of...
07.10.2025Precision Oncology Pioneer Trogenix Secures Landmark €80M Series A for Curative Cancer FightTrogenix, an Edinburgh-based biotech, secured a monumental €80 million Series A funding. This capital empowers its pursuit of curative cancer treatments for aggressive solid tumors. The firm's Odysseus platform uses advanced gene control an...
06.10.2025Edin Uni Spinout Trogenix Raises £70M to Treat Aggressive CancersUniversity of Edinburgh spinout Trogenix, which is developing curative therapies for aggressive, treatment-resistant cancers, has completed Series A financing of £70 million. The funding will allow the biotech company to rapidly advance its...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In